CareDx Inc (CDNA) - Product Pipeline Analysis, 2018 Update

CareDx Inc (CDNA) - Product Pipeline Analysis, 2018 Update


  • Products Id :- GDME26721PD
  • |
  • Pages: 33
  • |
  • |
  • |
  Request for Sample Report
  Request A Quote

Executive Summary

Summary

CareDx Inc (CareDx), formerly XDx Inc, is a commercial stage molecular diagnostics company that develops, markets, and delivers diagnostic surveillance solutions. The company offers commercialized testing solution, the AlloMap heart transplant molecular test, is a noninvasive blood test used which helps clinicians to monitor and identify acute cellular rejection in heart transplant recipients. It develops products for transplant monitoring including AlloSure, a next-generation sequencing test to detect donor-derived cell-free DNA after transplantation. CareDx also develop and commercialize post-transplant surveillance solutions to improve recipient outcomes. It offers novel surveillance management solutions to transform long-term patient care in transplantation. CareDx is headquartered in Brisbane, California, the US.

This report is a source for data, analysis, and actionable intelligence on the company's portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments

- The report analyzes all pipeline products in development for the company CareDx Inc

- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)

- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date

- The report provides detailed description of products in development, technical specification and functions

- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to Buy:

- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape

- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio

- To formulate effective Research & Development strategies

- Develop market-entry and market expansion strategies

- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return

- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline

- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

- Develop competition strategies by identifying the status and likely launch of the competitors' pipeline products through review of the clinical trials, stage and of development, etc

- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio

Note: Some sections may be missing if data is unavailable for the company



Read More



Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications

+91-9015378249

Table of Contents

Table of Contents 2

List of Tables 3

List of Figures 3

CareDx Inc Company Overview 4

CareDx Inc Company Snapshot 4

CareDx Inc Pipeline Products and Ongoing Clinical Trials Overview 4

CareDx Inc - Pipeline Analysis Overview 6

CareDx Inc - Key Facts 6

CareDx Inc - Major Products and Services 7

CareDx Inc Pipeline Products by Development Stage 8

CareDx Inc Pipeline Products Overview 10

cfDNA Assay - Heart 10

cfDNA Assay - Heart Product Overview 10

cfDNA Assay - Liver 11

cfDNA Assay - Liver Product Overview 11

cfDNA Assay - Lung 12

cfDNA Assay - Lung Product Overview 12

Diagnostic Test - Crohn's Disease 13

Diagnostic Test - Crohn's Disease Product Overview 13

Diagnostic Test - Multiple Sclerosis 14

Diagnostic Test - Multiple Sclerosis Product Overview 14

Diagnostic Test - Rheumatoid Arthritis 15

Diagnostic Test - Rheumatoid Arthritis Product Overview 15

Diagnostic Test - Sjogren's Syndrome 16

Diagnostic Test - Sjogren's Syndrome Product Overview 16

Diagnostic Test - Systemic Lupus Erythematosus 17

Diagnostic Test - Systemic Lupus Erythematosus Product Overview 17

Olerup QTYPE 18

Olerup QTYPE Product Overview 18

Post Transplant Management-Lung Transplant 19

Post Transplant Management-Lung Transplant Product Overview 19

CareDx Inc - Key Competitors 20

CareDx Inc - Key Employees 21

CareDx Inc - Locations And Subsidiaries 22

Head Office 22

Other Locations & Subsidiaries 22

Recent Developments 23

CareDx Inc, Recent Developments 23

Jun 28, 2018: Flatiron Health CMO/CSO Joins CareDx Board of Directors 23

Jun 19, 2018: CareDx set to join Russell 2000, Russell 3000 and Russell Microcap Indexes 23

Jun 01, 2018: Key CareDx Events Scheduled at American Transplant Congress 2018 23

May 10, 2018: CareDx Reports First Quarter Results 24

May 01, 2018: CareDx Activities at American Transplant Congress 25

Apr 13, 2018: Olerup QTYPE Receives CE Mark Certification 26

Apr 10, 2018: CareDx Launches HeartCare for Heart Transplant Recipients 26

Mar 22, 2018: CareDx Announces Fourth Quarter And FY2017 Financial Results 27

Mar 18, 2018: Olerup QTYPE now available on Applied Biosystems platforms 28

Feb 05, 2018: CareDx Leadership in cfDNA Highlighted at CEoT 28

Appendix 30

Methodology 30

About GlobalData 33

Contact Us 33

Disclaimer 33

List of Figures

CareDx Inc Pipeline Products by Equipment Type 5

CareDx Inc Pipeline Products by Development Stage 8

List of Tables

CareDx Inc Pipeline Products and Ongoing Clinical Trials Overview 4

CareDx Inc Pipeline Products by Equipment Type 5

CareDx Inc Pipeline Products by Indication 5

CareDx Inc, Key Facts 6

CareDx Inc, Major Products and Services 7

CareDx Inc Number of Pipeline Products by Development Stage 8

CareDx Inc Pipeline Products Summary by Development Stage 9

cfDNA Assay - Heart - Product Status 10

cfDNA Assay - Heart - Product Description 10

cfDNA Assay - Liver - Product Status 11

cfDNA Assay - Liver - Product Description 11

cfDNA Assay - Lung - Product Status 12

cfDNA Assay - Lung - Product Description 12

Diagnostic Test - Crohn's Disease - Product Status 13

Diagnostic Test - Crohn's Disease - Product Description 13

Diagnostic Test - Multiple Sclerosis - Product Status 14

Diagnostic Test - Multiple Sclerosis - Product Description 14

Diagnostic Test - Rheumatoid Arthritis - Product Status 15

Diagnostic Test - Rheumatoid Arthritis - Product Description 15

Diagnostic Test - Sjogren's Syndrome - Product Status 16

Diagnostic Test - Sjogren's Syndrome - Product Description 16

Diagnostic Test - Systemic Lupus Erythematosus - Product Status 17

Diagnostic Test - Systemic Lupus Erythematosus - Product Description 17

Olerup QTYPE - Product Status 18

Olerup QTYPE - Product Description 18

Post Transplant Management-Lung Transplant - Product Status 19

Post Transplant Management-Lung Transplant - Product Description 19

CareDx Inc, Key Employees 21

CareDx Inc, Subsidiaries 22

Glossary 32

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to sales [@] kenresearch.com
 

Response Genetics Inc

Vermillion Inc

Natera Inc

CareDx Inc, Product, Pipeline, Product Pipeline, Key Pipeline, Products by Equipment Type, Equipment Type, Therapy Area, Products by Therapy Area, Development Stage, Products by Development Stage, Milestone, Products by Milestone, Major Products, Brands, No of Products, Device Class, Market, Territory, Product Name, Therapy Name, Trial Name, Trial, Indication, Summary, Event Type, Clinical Trial, MileStone, Product Status, Product Description, Description, Patent, Patent Details, Competitors, Key Employees, Subsidiaries, Locations, News, Events, Developments, medical devices, business description, company facts, trial phase, approval, estimated, technology, product patent details, phase, trial status, trial objective, trial design, trial site, business strategies, trends, pipeline and technology, sales strategies

select a license
Single User License
USD 750 INR 53940
Site License
USD 1500 INR 107880
Corporate User License
USD 2250 INR 161820

NEWSLETTER BY CATEGORY




Testimonials

I appreciate their diligence and determination in customizing the research project. The data proves to be valuable and accurate. I would, in future, definitely use their services again...

I would like to thank Ken research team for meeting our report deliverables. The report is very good and we appreciate your well cooperation. ...

The research you conducted was very helpful for us and the integrity of your research approach gave us great confidence in the data. Look forward to collaborating again in future...

An excellent provider. Thorough, precise and outstanding insight. They drill down to what we need and their reports are effective at integrating text with supporting graphics and charts. Their reports are a great resource to go back too. ...

Coherent, high-quality, thoroughly-researched reports. We received a very quick response to all our queries which eventually expedited the entire process....



Ken Research Private Limited, Unit 14, Tower B3, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India

download

Company Brochure

Engage with Us

sales [@] kenresearch.com